October 2012

Compliance Issues? First, Don’t Panic.

September 27, 2012

A hurricane is coming. You heard about it on the radio. Everyone in the family jumps to it. You rush to the grocery store and pile as many cans of Chef Boyardee as will fit in your cart. Your spouse nails boards across the windows. The kids run around the house collecting candles. But when […]

SHOWCASE FEATURE: Regulatory Affairs: Regulating the Globe

September 27, 2012

The growing pressure on pharma companies and regulators to ensure and enforce product potency and safety has resulted in a strong trend toward harmonization among regulatory bodies throughout the world. “Regulatory professionals can no longer operate with a local-only mentality; every product and regulatory decision must consider a global perspective.” The FDA report, Pathway to […]

China’s Pharma Star Shines Bright

September 27, 2012

With a large patient population, government commitment to healthcare reform, a huge depth of scientific talent, and a powerful economy, China has been identified by many as the world’s most important emerging biopharma market. With a population of 1.3 billion people, China is both the world’s most populous nation and the fastest-growing major economy. China […]

Take Charge of Your Career: Next Steps

September 27, 2012

Experts discuss the importance of mentoring, sponsorship, and coaching in career development. Mentoring has been a common tool to help employees learn from and take advantage of the experience of others. A consensus among our experts is that all employees can benefit from having mentors at different stages of their careers, especially in the pharmaceutical […]

Segmentation and Personalization Brings Targets into Focus

September 27, 2012

With the tools that are available today, the industry can hone in on the right targets. Sophisticated technology and a more diverse field of targets are creating a new segmentation model that moves away from the practice of solely monitoring prescribing behaviors. The new environment requires strategies that can effectively determine the most appropriate channels […]

A Changing Mindset: Managing Managed Markets

September 27, 2012

The industry must revamp its managed markets strategies from the ground up to survive in the new reality of value propositions. Since the onset of healthcare reform, the role and power of payers have been growing steadily and has reached a point of painful reality for the industry. Starting today, companies need to abandon knee-jerk […]

Industry Spotlight: The Man, the Molecule, the Market: Untangling Alzheimer’s Mystery

September 27, 2012

Alzheimer’s disease is a progressive brain disorder that damages and eventually destroys brain cells, leading to loss of memory, thinking, and other brain functions. Alzheimer’s is not a part of normal aging, but results from a complex pattern of abnormal changes. It usually develops slowly and gradually worsens as more brain cells wither and die. […]

Last Word

September 27, 2012

Developing a Patient-Centric Business Model Rob Bazemore, President of Janssen Biotech, ­discusses why and how the company is implementing a patient-centric focus throughout all levels of the company. PV: What does being patient-centric mean for Janssen Biotech? Bazemore: Patients are our top priority. Several organizational imperatives are driving our focus on improving a patient-centric approach. […]

Talent Pool

September 27, 2012

Pharmaceutical Pool Dr. Lawrence Bloch Infinity Names Business Chief Lawrence Bloch, M.D., has joined Infinity Pharmaceuticals as executive VP, chief financial officer, and chief business officer. Dr. Bloch is responsible for the company’s corporate, financial, and business development strategies and operations. Dr. Bloch brings to Infinity more than 12 years of experience in building and leading […]

PharmaTrax

September 27, 2012

Sales, marketing, And R&D?Trends affecting the healthcare industry Oncologists Rate Genentech Highest in Image Trend: Analysts correlate overall company image with key behaviors such as recommending products to colleagues, providing additional time for sales reps and medical science liaisons, and attending company-sponsored programs. Genentech and Novartis have the best image among oncologists and hematologists in […]

Social Media

September 27, 2012

Social Media Innovators Move Beyond Corporate Facebook Pages Trend: More digital channels, more diversity, more ways to reach consumers GSK Leverages Olympic Sponsorship Through Digital Media This summer, GlaxoSmithKline provided the official laboratory services for the London 2012 Olympic and Paralympic Games. Through a partnership with King’s College London, the pharma company provided facilities and […]

Tools of the Trade

September 27, 2012

New electronic and web-based applications, sites, and technologies Physicians Interactive Unveils Zero-Click eCoupon Solution Trend: As more healthcare practitioners (HCPs) employ electronic prescription systems, they are looking for ways to build cost savings and adherence incentives into the workflow. Physicians Interactive (PI) has introduced eCoupon, an automated voucher and coupon distribution solution that provides patients […]

What’s New

September 27, 2012

DIA and HBA Collaborate on Women’s Leadership Project Trend: The associations’ career-building initiative focuses on regulatory, medical, legal, and compliance functions within the life-sciences industry. The DIA/HBA Leadership Project is a multiyear initiative launched by DIA and the Healthcare Businesswomen’s Association (HBA) to advance the careers of women involved in the regulatory, medical, legal, and […]

UpFront

September 27, 2012

Awards… Amylin’s Diabetes Product Honored Amylin’s Bydureon has been honored by the Distribution Management Awards for Notable Achievements in Healthcare (DIANA) for the category of best new pharmaceutical product introduction. The DIANA award recognizes pharmaceutical and consumer product manufacturers that set the standard for innovation. Bydureon is a once-weekly formulation indicated for Type 2 diabetes. […]

Letter from the Editor

September 27, 2012

The Long Goodbye: Alzheimer’s Disease The numbers are almost as daunting as Alzheimer’s disease itself. Today, 5.4 million Americans are living with the disease. Every four seconds around the world, someone is diagnosed with dementia. According to Alzheimer’s Disease International, there are 7.7 million new cases of dementia each year. If dementia care were a […]

FEEDBACK